NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $734,857 | -11.7% | 7,811 | -5.3% | 0.01% | -11.1% |
| Q2 2023 | $832,005 | +2.0% | 8,245 | -7.0% | 0.01% | 0.0% |
| Q1 2023 | $816,040 | -10.5% | 8,870 | -11.7% | 0.01% | -18.2% |
| Q4 2022 | $911,284 | +19.3% | 10,045 | 0.0% | 0.01% | +10.0% |
| Q3 2022 | $764,000 | -17.4% | 10,045 | -8.2% | 0.01% | -9.1% |
| Q2 2022 | $925,000 | -11.6% | 10,943 | -8.2% | 0.01% | 0.0% |
| Q1 2022 | $1,046,000 | +0.7% | 11,923 | +0.4% | 0.01% | +10.0% |
| Q4 2021 | $1,039,000 | -9.4% | 11,873 | -15.4% | 0.01% | -9.1% |
| Q3 2021 | $1,147,000 | -20.2% | 14,026 | -11.0% | 0.01% | -26.7% |
| Q2 2021 | $1,438,000 | +8.1% | 15,761 | +1.3% | 0.02% | 0.0% |
| Q1 2021 | $1,330,000 | -27.7% | 15,564 | -20.1% | 0.02% | -28.6% |
| Q4 2020 | $1,840,000 | +0.5% | 19,484 | -7.5% | 0.02% | -8.7% |
| Q3 2020 | $1,831,000 | -4.1% | 21,058 | -3.7% | 0.02% | -11.5% |
| Q2 2020 | $1,909,000 | +10.9% | 21,858 | +4.7% | 0.03% | -10.3% |
| Q1 2020 | $1,722,000 | -15.3% | 20,886 | -2.7% | 0.03% | +7.4% |
| Q4 2019 | $2,034,000 | -27.6% | 21,476 | -33.6% | 0.03% | -34.1% |
| Q3 2019 | $2,810,000 | +3.3% | 32,341 | +8.6% | 0.04% | +2.5% |
| Q2 2019 | $2,719,000 | -20.2% | 29,775 | -16.0% | 0.04% | -23.1% |
| Q1 2019 | $3,409,000 | +0.3% | 35,463 | -10.5% | 0.05% | -16.1% |
| Q4 2018 | $3,400,000 | -3.7% | 39,619 | -3.3% | 0.06% | +10.7% |
| Q3 2018 | $3,531,000 | +9.6% | 40,982 | -3.9% | 0.06% | 0.0% |
| Q2 2018 | $3,223,000 | -28.8% | 42,663 | -23.8% | 0.06% | -31.7% |
| Q1 2018 | $4,524,000 | -31.2% | 55,960 | -28.6% | 0.08% | -32.2% |
| Q4 2017 | $6,580,000 | -11.2% | 78,376 | -9.2% | 0.12% | -15.4% |
| Q3 2017 | $7,410,000 | -0.8% | 86,314 | -1.6% | 0.14% | -3.4% |
| Q2 2017 | $7,473,000 | +9.2% | 87,708 | -4.8% | 0.15% | +3.5% |
| Q1 2017 | $6,843,000 | +1.4% | 92,134 | -0.5% | 0.14% | -4.7% |
| Q4 2016 | $6,747,000 | -9.0% | 92,628 | -1.3% | 0.15% | -11.8% |
| Q3 2016 | $7,413,000 | -12.0% | 93,889 | -8.1% | 0.17% | -12.4% |
| Q2 2016 | $8,425,000 | +8.6% | 102,109 | -4.7% | 0.19% | +6.0% |
| Q1 2016 | $7,761,000 | -20.0% | 107,143 | -5.0% | 0.18% | -23.8% |
| Q4 2015 | $9,705,000 | -16.1% | 112,796 | -4.1% | 0.24% | -18.6% |
| Q3 2015 | $11,566,000 | 0.0% | 117,609 | 0.0% | 0.30% | 0.0% |
| Q2 2015 | $11,566,000 | -1.4% | 117,609 | -1.2% | 0.30% | -0.3% |
| Q1 2015 | $11,735,000 | -46.8% | 119,000 | -50.0% | 0.30% | +4.6% |
| Q4 2014 | $22,060,000 | +95.0% | 238,080 | +98.1% | 0.28% | -7.5% |
| Q3 2014 | $11,315,000 | +3.7% | 120,205 | -0.2% | 0.31% | +3.7% |
| Q2 2014 | $10,909,000 | +3.0% | 120,505 | -3.3% | 0.30% | +1.7% |
| Q1 2014 | $10,592,000 | +4.8% | 124,580 | -0.9% | 0.29% | +3.9% |
| Q4 2013 | $10,103,000 | +4.7% | 125,686 | -0.1% | 0.28% | -5.1% |
| Q3 2013 | $9,647,000 | +6.3% | 125,755 | -2.0% | 0.29% | +3.5% |
| Q2 2013 | $9,071,000 | – | 128,282 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |